Originally developed at Monash University as part of research into the lipolytic domain of hGH, AOD-9604 retains many of the fat-mobilising characteristics of full-length growth hormone while lacking the broader growth-promoting and insulin-resistance effects associated with the parent molecule
ROS can damage cellular components such as lipids, proteins, and DNA, leading to cell death and loss of cardiac contractile function
The booming class of GLP-1 drugs that includes Ozempic and Wegovy is not only effective for diabetes and obesity, but is also showing early potential to help with conditions involving the brain, like mental health disorders, Alzheimers, and even, as new study results suggest Parkinsons disease
Efficacy of the nootropic supplement Mind Lab Pro on memory in adults: Double blind, placebo-controlled study
Mbonu, C., Azeta, J
Is retatrutide available anywhere as a Zepbound alternative